Related Experiment Video
Updated: Feb 24, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Ureaplasma urealyticum necrotizing soft tissue infection
Ian Gassiep1, Letitia Gore2, Joanne L Dale3
1Department of Infectious Diseases, Princess Alexandra Hospital, 199 Ipswich Rd, Woolloongabba, QLD, 4102, Australia; School of Medicine, University of Queensland, St Lucia, QLD, 4072, Australia.
Abstract:
Ureaplasma urealyticum is a urogenital commensal and often associated with localised infection. With the advent of monoclonal immunosuppressive therapy and improved diagnostic methods, reports of non-urogenital infections are accumulating. We report a rare case of U. urealyticum necrotizing soft tissue infection and left hip septic arthritis in a hypogammaglobulinaemic patient. Consideration of this organism as an etiological agent, and potential early use of nucleic-acid diagnostic investigation with empiric therapy including activity against Ureaplasma in this patient population may be warranted.
Insights
Ureaplasma urealyticum can cause rare, severe infections outside the urogenital tract, particularly in immunocompromised patients. Early diagnosis and treatment are crucial for managing these serious Ureaplasma urealyticum soft tissue and joint infections.
Area of Science:
- Infectious Diseases
- Microbiology
- Immunology
Background:
- Ureaplasma urealyticum is a common urogenital bacterium.
- It is typically associated with localized urogenital infections.
- Increasing reports link it to non-urogenital infections, especially with advancements in immunosuppressive therapies.
Observation:
- A rare case of Ureaplasma urealyticum infection is presented.
- The infection manifested as necrotizing soft tissue infection and septic arthritis of the left hip.
- The patient was hypogammaglobulinaemic, indicating an immunocompromised state.
Findings:
- Ureaplasma urealyticum was identified as the causative agent.
- The infection involved severe soft tissue necrosis and joint destruction.
- This highlights the potential for Ureaplasma urealyticum to cause invasive, systemic disease.
Implications:
- Clinicians should consider Ureaplasma urealyticum in non-urogenital infections, particularly in immunocompromised individuals.
- Early nucleic-acid diagnostic investigations are recommended.
- Empiric therapy should include agents with activity against Ureaplasma, especially in high-risk patients.
Related Concept Videos
Acute Pyelonephritis I: Introduction
Urinary Tract Infection II: Pathophysiology
Acute Pyelonephritis II: Diagnostic Studies and Management
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Rheumatic Heart Disease I: Introduction
Bacterial Phylum Spirochaetes

